Cell And Gene Technologies

© GettyImages/Ca-ssis

Lonza: Robust industry fundamentals are supportive of growth

By Jane Byrne

Despite an uncertain macroeconomic environment, Lonza says its ‘resilient’ business model and sustained market demand delivered a strong financial performance in 2022, in line with the Swizterland based CDMO’s outlook.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All